Hypoxia-inducible factor-1α (HIF-1α), a well-studied angiogenesis pathway, plays an essential role in angiogenesis-osteogenesis coupling. Targeting the HIF-1a pathway frequently leads to successful reconstruction of large-sized bone defects through promotion of angiogenesis. Dimethyloxalylglycine (DMOG) small molecule regulates the stability of HIF-1α at normal oxygen tension by mimicking hypoxia, which subsequently accelerates angiogenesis. The current study aims to develop a novel construct by seeding adipose derived mesenchymal stem cells (ADMSCs) onto a scaffold that contains DMOG to induce angiogenesis and regeneration of a critical size calvarial defect in a rat model. The spongy scaffolds have been synthesized in the presence and ...
Abstract Background There is a critical need for the management of large bone defects. The purpose o...
Leveraging the differential response of genes to mechanical loading may allow for the identification...
ABSTRACT: Treatment of large bone defects using synthetic scaffolds remain a challenge mainly due to...
Development of hypoxia-mimicking bone tissue engineering scaffolds is of great importance in stimula...
Large bone defect repair requires biomaterials that promote angiogenesis and osteogenesis. In presen...
AIM Pharmacological inhibitors of prolyl hydroxylases, also termed hypoxia-mimetic agents (HMAs),...
<div><p>Hypoxia-inducible factor 1-α (HIF-1α) plays a critical role in angiogenesis-osteogenesis cou...
Biomaterials with excellent osteogenic and angiogenic activities are desirable to repair massive bon...
Abstract Reconstruction of large bone defects remains a clinical challenge because current approache...
Background: Bone regeneration studies involving the use of chitosan–hydroxyapatite (Ch-HA) scaffold ...
One of the major challenges of bone tissue engineering applications is to construct a fully vascular...
Current clinical therapies for critical-sized bone defects (CSBDs) remain far from ideal. Previous s...
The healing of large, critically sized bone defects remains an unmet clinical need in modern orthop...
Multifunctional bioactive materials with the ability to stimulate osteogenesis and angiogenesis of s...
Angiogenesis and osteogenesis coupling processes are essential for bone regeneration, and human bone...
Abstract Background There is a critical need for the management of large bone defects. The purpose o...
Leveraging the differential response of genes to mechanical loading may allow for the identification...
ABSTRACT: Treatment of large bone defects using synthetic scaffolds remain a challenge mainly due to...
Development of hypoxia-mimicking bone tissue engineering scaffolds is of great importance in stimula...
Large bone defect repair requires biomaterials that promote angiogenesis and osteogenesis. In presen...
AIM Pharmacological inhibitors of prolyl hydroxylases, also termed hypoxia-mimetic agents (HMAs),...
<div><p>Hypoxia-inducible factor 1-α (HIF-1α) plays a critical role in angiogenesis-osteogenesis cou...
Biomaterials with excellent osteogenic and angiogenic activities are desirable to repair massive bon...
Abstract Reconstruction of large bone defects remains a clinical challenge because current approache...
Background: Bone regeneration studies involving the use of chitosan–hydroxyapatite (Ch-HA) scaffold ...
One of the major challenges of bone tissue engineering applications is to construct a fully vascular...
Current clinical therapies for critical-sized bone defects (CSBDs) remain far from ideal. Previous s...
The healing of large, critically sized bone defects remains an unmet clinical need in modern orthop...
Multifunctional bioactive materials with the ability to stimulate osteogenesis and angiogenesis of s...
Angiogenesis and osteogenesis coupling processes are essential for bone regeneration, and human bone...
Abstract Background There is a critical need for the management of large bone defects. The purpose o...
Leveraging the differential response of genes to mechanical loading may allow for the identification...
ABSTRACT: Treatment of large bone defects using synthetic scaffolds remain a challenge mainly due to...